Space Pharmaceuticals, an AI-driven chemical space drug discovery company based in Basel, Switzerland, announced the completion of a Series A financing round of CHF 12 million, led by Venture Capital firm Cowin Capital.
Spinned-off from 20 years of computational chemistry research from Prof. Jean-Louis Reymond, University of Bern, Switzerland, Space Pharmaceuticals’ GDBspace drug discovery engine has a unique approach to the design of the largest and most diverse small molecule (incl. peptides and peptidomimetics) library till date, mapped with molecular fingerprints to decode this chemical space. A portfolio of Artificial Intelligence (AI)-augmented technologies and state-of-the-art algorithms, empower the evaluation of billions of molecules to design drugs faster and cheaper. The Space Peptides laboratory arm is specialized in peptide manufacturing, as well as in vitro / in vivo validation of the molecules of interests.
Dr. Runze He, CEO of Space Pharmaceuticals says: “The confidence of our investors together with successful partnerships with established pharma and biotech companies further validates our AI-driven discovery platform to de-risk drug discovery programs, increase success rates, and significantly reducing time and costs. With some of the first AI-designed drugs entering the clinic, we are convinced of the value of AI in de-risking and transforming the pharmacoeconomics of drug discovery.”
About Space Pharmaceuticals
Space Pharmaceuticals AG (“Space Pharmaceuticals”) is an AI-based drug discovery and peptide manufacture company. Its proprietary GDBspace discovery engine applies chemical space-based drug discovery, combined with artificial intelligence, to identify small molecules (incl. peptides and peptidomimetics) of interests in a precise and time-efficient manner –
hence de-risking projects, increasing success rates, and significantly reducing time and costs. The Space Peptides laboratory arm is specialized in peptide manufacturing, as well as in vitro / in vivo validation of the molecules of interests. For more information, please visit Space Pharmaceutical’s website at www.gdbspace.com, www.spacepeptides.com